Optimizing intravenous fosfomycin dosing in combination with carbapenems for treatment of Pseudomonas aeruginosa infections in critically ill patients based on pharmacokinetic/pharmacodynamic (PK/PD) simulation
Author(s) -
Orarik Asuphon,
Preecha Montakantikul,
Jantana Houngsaitong,
Pattarachai Kiratisin,
Paveena Sonthisombat
Publication year - 2016
Publication title -
international journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.278
H-Index - 89
eISSN - 1878-3511
pISSN - 1201-9712
DOI - 10.1016/j.ijid.2016.06.017
Subject(s) - fosfomycin , carbapenem , pseudomonas aeruginosa , pharmacodynamics , antibiotics , medicine , pharmacokinetics , dosing , minimum inhibitory concentration , pharmacology , microbiology and biotechnology , biology , bacteria , genetics
The purpose of the study was to determine the optimal dosing regimen of intravenous fosfomycin for the treatment of Pseudomonas aeruginosa (PA) based on PK/PD targets.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom